These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24887264)

  • 1. The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes.
    Lasagna-Reeves CA; Sengupta U; Castillo-Carranza D; Gerson JE; Guerrero-Munoz M; Troncoso JC; Jackson GR; Kayed R
    Acta Neuropathol Commun; 2014 May; 2():56. PubMed ID: 24887264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tau oligomeric seeds in progressive supranuclear palsy.
    Gerson JE; Sengupta U; Lasagna-Reeves CA; Guerrero-Muñoz MJ; Troncoso J; Kayed R
    Acta Neuropathol Commun; 2014 Jun; 2():73. PubMed ID: 24927818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
    Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
    Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
    Montalbano M; Majmundar L; Sengupta U; Fung L; Kayed R
    Brain Pathol; 2023 Jan; 33(1):e13112. PubMed ID: 36054524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein aggregation is associated with cellular senescence in the brain.
    Musi N; Valentine JM; Sickora KR; Baeuerle E; Thompson CS; Shen Q; Orr ME
    Aging Cell; 2018 Dec; 17(6):e12840. PubMed ID: 30126037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy.
    Ward SM; Himmelstein DS; Ren Y; Fu Y; Yu XW; Roberts K; Binder LI; Sahara N
    Neurobiol Dis; 2014 Jul; 67():37-48. PubMed ID: 24631720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
    Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
    J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.
    Lasagna-Reeves CA; Castillo-Carranza DL; Jackson GR; Kayed R
    Curr Alzheimer Res; 2011 Sep; 8(6):659-65. PubMed ID: 21605039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.
    Takahashi M; Uchikado H; Caprotti D; Weidenheim KM; Dickson DW; Ksiezak-Reding H; Pasinetti GM
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1157-69. PubMed ID: 17146290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
    Yoshida M
    Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
    Mori H; Nishimura M; Namba Y; Oda M
    Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.